EJ6-28911-91778
4 vaccinations
6 coded responses
37 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 630 / MO
- Registered
- 2021-03-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-29
Registered in v-safe
-
2021-03-29
Dose 2 — Pfizer-BioNTech
- 2021-03-29
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal pain — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Abdominal crampsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
- 2021-04-01
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Headache, NauseaFree text: But I dont think they are related to vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-06-28
-
2021-09-29
Survey response — 6 months, dose 2MedDRA: Eye allergy, Eye pruritus, Lacrimation increased, Rhinorrhoea, Sneezing — Feeling: GoodFree text: Allergy in eyes. Itchy watery eyes, runny nose, sneezing. Had never experienced anything as intense as this beforeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, DiarrheaAdult check-in
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-19
- 2021-10-28
- 2021-11-02
-
2021-11-09
Survey response — day 35, dose 3MedDRA: Headache — Feeling: GoodFree text: Experiencing headaches that seem to have started after the booster. Not sure if related. I have had an occasional headache in the past, but they are now more frequent. One or two most weeks. Some have been more intense than the ones in the pastMedDRA releases: 2024-11 · check-in free text available
- 2021-11-16
- 2022-01-04
- 2022-04-05
-
2022-05-05
Dose 4 — Pfizer-BioNTech
- 2022-05-13
- 2022-05-19
- 2022-05-26
- 2022-06-02
- 2022-06-16
- 2022-08-04
-
2022-11-03
Survey response — 6 months, dose 4MedDRA: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test negative — Feeling: GoodFree text: Covid positive on 19 October. Almost no symptoms. Only tested because a household member was COVID positive. I tested negative on 30 October. So far I have not noticed any lingering effects.MedDRA releases: 2024-11 · check-in free text available
-
2023-05-05
Survey response — 12 months, dose 4MedDRA: Dizziness, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-05-05
Report sent to call center — 12 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2023-05-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-05-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Abdominal cramps
Systemic reaction (other): But I dont think they are related to vaccine.
Release 9 — 6 months, dose 2
Symptoms: Allergy in eyes. Itchy watery eyes, runny nose, sneezing. Had never experienced anything as intense as this before
Release 10 — day 35, dose 3
Symptoms: Experiencing headaches that seem to have started after the booster. Not sure if related. I have had an occasional headache in the past, but they are now more frequent. One or two most weeks. Some have been more intense than the ones in the past cut off by CDC
Release 12 — 6 months, dose 4
Symptoms: Covid positive on 19 October. Almost no symptoms. Only tested because a household member was COVID positive. I tested negative on 30 October. So far I have not noticed any lingering effects.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Eye allergy | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Abdominal pain | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release